EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)

被引：2
|
作者：
Winthrop, Kevin [1 ]
Eagle, Gina [1 ]
Morimoto, Kozo [1 ]
Castellotti, Paola Francesca [1 ]
O'Donnell, Anne [1 ]
Ruoss, Stephen [1 ]
Aksamit, Timothy [1 ]
Nezamis, James [1 ]
Griffith, David [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CHEST | 2018年 / 154卷 / 04期
关键词：
D O I：
10.1016/j.chest.2018.08.160
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：182A / 183A
页数：2
相关论文
共 50 条
  • [41] Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease
    Christopher M. Rubino
    Nikolas J. Onufrak
    Jakko van Ingen
    David E. Griffith
    Sujata M. Bhavnani
    Dayton W. Yuen
    Kevin C. Mange
    Kevin L. Winthrop
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2021, 46 : 573 - 574
  • [42] Inhaled Amikacin For The Treatment Of Pulmonary Mycobacterium Avium Complex (mac) Infection
    Benwill, J. L.
    Philley, J. V.
    Taskar, V.
    Brown-Elliott, B. A.
    Griffith, D. E.
    Wallace, R. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [43] A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused by mycobacterium avium complex (MAC)
    Griffith, David
    Flume, Patrick
    Winthrop, Kevin
    Thomson, Rachel
    Wagner, Dirk
    Van Ingen, Jakko
    Micioni, Liza
    McGinnis, John P., II
    Fernandez, Carlos
    Eagle, Gina
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [44] SURVEY ON USE AND PERCEPTION OF AMIKACIN FOR TREATMENT OF MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE IN THE UK
    Obradovic, M.
    Van der Laan, R.
    Hale, J.
    Gerden, E.
    Musson, L.
    [J]. THORAX, 2021, 76 : A177 - A178
  • [45] Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease A NTM-NET study
    Zweijpfenning, Sanne Maria Henriette
    Chiron, Raphael
    Essink, Sharon
    Schildkraut, Jodie
    Akkerman, Onno W.
    Aliberti, Stefano
    Altenburg, Josje
    Arets, Bert
    van Braeckel, Eva
    Delaere, Benedicte
    Gohy, Sophie
    Haarman, Eric
    Lorent, Natalie
    McKew, Genevieve
    Morgan, Lucy
    Wagner, Dirk
    van Ingen, Jakko
    Hoefsloot, Wouter
    [J]. CHEST, 2022, 162 (01) : 76 - 81
  • [46] Treatment for Mycobacterium avium complex lung disease
    Pan, Sheng-Wei
    Shu, Chin-Chung
    Feng, Jia-Yih
    Su, Wei-Juin
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 : S67 - S75
  • [47] Treatment of pulmonary disease caused by Mycobacterium avium complex
    Shimokata, K
    [J]. INTERNAL MEDICINE, 2003, 42 (08) : 627 - 628
  • [48] Therapeutic outcomes for cavitary Mycobacterium avium complex (MAC) lung disease
    Griffith, David
    Brown-Elliott, Barbara
    Shepherd, Sara
    Philley, Julie
    Wallace, Richard
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [49] TREATMENT PATTERNS AND HEALTH CARE RESOURCE UTILIZATION AMONG PATIENTS WITH POTENTIALLY TREATMENT-REFRACTORY MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE IN THE UNITED STATES
    Winthrop, Kevin L.
    Wang, Ping
    Lucci, Matthew
    Welch, Emily
    Shah, Bonny
    Hassan, Mariam
    [J]. CHEST, 2023, 164 (04) : 768A - 769A
  • [50] Treatment of refractory mycobacterium avium complex lung disease with a moxifloxacin-containing regimen
    Hong, Goohyeon
    Kim, Su-Young
    Jeong, Byeong-Ho
    Park, Hye Yun
    Jeon, Kyeongman
    Kwon, O. Jung
    Lee, Seung-Heon
    Kim, Chang Ki
    Shin, Sung Jae
    Koh, Won-Jung
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345